Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
36°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ABBV
Recent news which mentions ABBV
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
October 03, 2024
Tickers
ABBV
GSK
NEWS
NVO
Tags
NVO
PFE
Benzinga
From
Benzinga
5 Best Dividend Growth Stocks to Buy in October
October 02, 2024
Tickers
ABBV
AXP
BAC
COST
Tags
ABBV
Recent Press Releases
AXP
From
Motley Fool
Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
September 30, 2024
Tickers
ABBV
ACN
DIS
META
Tags
Kevin Simpson
Halftime Report Final Trades
Markets
From
Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
September 27, 2024
Tickers
ABBV
Tags
Trading Ideas
Short Sellers
ABBV
From
Benzinga
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
Tickers
ABBV
BMY
NEWS
Tags
Expert Ideas
Analyst Color
Top Stories
From
Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
September 26, 2024
Tickers
ABBV
NEWS
Tags
Trading Ideas
BZI/POD
Benzinga
From
Benzinga
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
September 26, 2024
Tickers
ABBV
NEWS
Tags
Briefs
News
Large Cap
From
Benzinga
Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
September 26, 2024
Tickers
ABBV
NVO
Tags
ABBV
Recent Press Releases
NVO
From
Motley Fool
Behind the Scenes of AbbVie's Latest Options Trends
September 24, 2024
Tickers
ABBV
Tags
Markets
BZI/UOA
Market News
From
Benzinga
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
September 20, 2024
Tickers
ABBV
BMY
NEWS
Tags
Market News
Stories That Matter
Top Stories
From
Benzinga
Spotlight on AbbVie: Analyzing the Surge in Options Activity
September 20, 2024
Tickers
ABBV
Tags
Market News
BZI/UOA
Markets
From
Benzinga
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
September 19, 2024
Tickers
ABBV
NEWS
Tags
Trading Ideas
ABBV
Benzinga
From
Benzinga
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
September 19, 2024
Tickers
ABBV
AZN
Tags
Market News
AZN
ABBV
From
Motley Fool
TransDigm, BJ's Wholesale, AbbVie And More On CNBC's 'Final Trades'
September 17, 2024
Tickers
ABBV
BJ
NEWS
SMH
Tags
Benzinga
Stephen L/ Weiss
Trading Ideas
From
Benzinga
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
September 16, 2024
Tickers
ABBV
ABT
Tags
ABT
Market News
ABBV
From
Motley Fool
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
September 14, 2024
Tickers
ABBV
MRNA
Tags
MRNA
ZLDP/F
Market News
From
Motley Fool
3 Stocks to Buy and Hold Forever
September 14, 2024
Tickers
ABBV
ABT
LLY
VRTX
Tags
Market News
ABT
Recent Press Releases
From
Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
September 14, 2024
Tickers
ABBV
BIP
BIPC
VZ
Tags
BIP
Recent Press Releases
ABBV
From
Motley Fool
Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
September 13, 2024
Tickers
ABBV
Tags
ABBV
Recent Press Releases
Market News
From
Motley Fool
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
September 11, 2024
Tickers
ABBV
ALVO
AMGN
CI
Tags
CVS
Benzinga
UNH
From
Benzinga
What the Options Market Tells Us About AbbVie
September 11, 2024
Tickers
ABBV
Tags
Market News
BZI/UOA
Markets
From
Benzinga
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
September 10, 2024
Tickers
ABBV
CAH
CVS
NEWS
Tags
Pharamceuticals
General
Legal
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.